Evidence map›Paper›PMID 23771691›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2013

Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction.

Xiangmin Zhao, Wei Zhang, Dongqi Xing, Peng Li, Jinyan Fu, Kaizheng Gong, Fadi G Hage, Suzanne Oparil, Yiu-Fai Chen

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Interleukin-8 in health and disease.Molecular biomedicine · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
  7. YQWY Decoction Improves Myocardial Remodeling via Activating the IL-10/Stat3 Signaling Pathway.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Xiangmin ZhaoVascular Biology and Hypertension Program, Division of Cardiovascular Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama;
Wei Zhang
Dongqi Xing
Peng Li
Jinyan Fu
Kaizheng Gong
Fadi G Hage
Suzanne Oparil
Yiu-Fai Chen
University of Alabama at Birmingham · USYangzhou University · CN

Funding

ATRIAL NATRIURETIC PEPTIDE IN PULMONARY HYPERTENSIONR01HL044195 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YIU-FAI · 1990 to 2010
$2.6M
UAB Biostatistics Pre-doctoral Training ProgramT32HL079888 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALLISON, DAVID B, CUTTER, GARY R · 2005 to 2014
$2.3M
Targeted Delivery of iPS-Endothelial Cells for the Repair of Cardiovascular InjurR01HL116727 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YIU-FAI · 2013 to 2016
$1.4M
AMPK activates calcium signaling necessary for endothelial barrier repairR01HL102296 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CREIGHTON, JUDY · 2010 to 2014
$1.4M
ANP Modulates Cardiac Remodeling via Cardiac FibroblastsR01HL080017 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHEN, YIU-FAI · 2006 to 2009
$1.4M
Impaired AMPK activity contributes to vascular pathogenesis associated with PHR03HL110803 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CREIGHTON, JUDY · 2012 to 2013
$143k
NHLBI NIH HHS R01HL-044195NHLBI NIH HHS R01HL-080017NHLBI NIH HHS R01 HL102296NHLBI NIH HHS R01 HL116727NHLBI NIH HHS R03 HL110803NHLBI NIH HHS T32 HL-079888NHLBI NIH HHS T32 HL079888
6 · The paper itself

Abstract

The endothelium is a dynamic component of the cardiovascular system that plays an important role in health and disease. This study tested the hypothesis that targeted delivery of endothelial cells (ECs) overexpressing neutrophil membrane IL-8 receptors IL8RA and IL8RB reduces acute myocardial infarction (MI)-induced left ventricular (LV) remodeling and dysfunction and increases neovascularization in the area at risk surrounding the infarcted tissue. MI was created by ligating the left anterior descending coronary artery in 12-wk-old male Sprague-Dawley rats. Four groups of rats were studied: group 1: sham-operated rats without MI or EC transfusion; group 2: MI rats with intravenous vehicle; group 3: MI rats with transfused ECs transduced with empty adenoviral vector (Null-EC); and group 4: MI rats with transfused ECs overexpressing IL8RA/RB (1.5 × 10⁶ cells post-MI). Two weeks after MI, LV function was assessed by echocardiography; infarct size was assessed by triphenyltetrazolium chloride (live tissue) and picrosirus red (collagen) staining, and capillary density and neutrophil infiltration in the area at risk were measured by CD31 and MPO immunohistochemical staining, respectively. When compared with the MI + vehicle and MI-Null-EC groups, transfusion of IL8RA/RB-ECs decreased neutrophil infiltration and pro-inflammatory cytokine expression and increased capillary density in the area at risk, decreased infarct size, and reduced MI-induced LV dysfunction. These findings provide proof of principle that targeted delivery of ECs is effective in repairing injured cardiac tissue. Targeted delivery of ECs to infarcted hearts provides a potential novel strategy for the treatment of acute MI in humans.

Indexed as

Ventricular RemodelingAdenoviridaeAnimalsCells, CulturedDisease Models, AnimalEndothelial CellsGenetic TherapyGenetic VectorsImmunohistochemistryInflammation MediatorsMaleMyocardial InfarctionMyocardiumNeovascularization, PhysiologicNeutrophil InfiltrationRatsInflammation MediatorsReceptors, Interleukin-8Recombinant Fusion Proteinscell therapyendothelial cellsinterleukin-8 receptorsmyocardial infarctionneovascularization

Identifiers

PMID23771691
PMCPMC3891247
OpenAlexW2107407141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.